Showing results (1671-1680 of 1,824) with videos related to
Sort By:
Pageof 183
Targeted Oncology|May 14, 2018
Discovery of a Potent and Mutant-Selective EGFR Inhibitor that Overcomes T790M-Mediated Resistance in Lung CancerDong Ha Kim, Yun Jung Choi, Seon Ye Kim, et al.Small (Weinheim an Der Bergstrasse, Germany)|May 26, 2023
Morphology and Performance Enhancement through the Strong Passivation Effect of Amphoteric Ions in Tin-based Perovskite Solar CellsDu Hyeon Ryu, Nasir Khan, Jong-Goo Park, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 28, 2025
Unveiling Formation Pathways of Ternary I-III-VI CuInS2 Quantum Dots and Their Effect on Photoelectrochemical Hydrogen GenerationHyo Cheol Lee, Hwapyong Kim, Kiwook Kim, et al.ACS Nano|November 14, 2022
Universal Ligands for Dispersion of Two-Dimensional MXene in Organic SolventsTae Yun Ko, Daesin Kim, Seon Joon Kim, et al.Prostate International|October 26, 2020
Parathyroid hormone is associated with prostate cancerWon Tae Kim, Woo Jin Bang, Sung Pil Seo, et al.Journal of Periodontology|January 4, 2007
Osteopromotion with synthetic oligopeptide-coated bovine bone mineral in vivoJun-Beom Park, Jue-Yeon Lee, Ho-Nam Park, et al.Gynecologic Oncology|December 3, 2014
Phase II study of gemcitabine and vinorelbine as second- or third-line therapy in patients with primary refractory or platinum-resistant recurrent ovarian and primary peritoneal cancer by the Korean Cancer Study Group (KCSG)_KCSG GY10-10Sook Hee Hong, Soohyeon Lee, Hoon-Gu Kim, et al.Journal of Korean Medical Science|May 18, 2019
Methylation Signature for Prediction of Progression Free Survival in Surgically Treated Clear Cell Renal Cell CarcinomaHo Won Kang, Hongyong Park, Sung Pil Seo, et al.Cancer Research and Treatment|June 19, 2019
Behaviors and Attitudes toward the Use of Complementary and Alternative Medicine among Korean Cancer PatientsJung Hye Kwon, Sang-Cheol Lee, Myung Ah Lee, et al.Blood Advances|September 17, 2021
Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutationsJiwon Koh, Insoon Jang, Seungchan Mun, et al.Pageof 183